Based on the key indicators related to Cassava Sciences' liquidity, profitability, solvency, and operating efficiency, Cassava Sciences may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At present, Cassava Sciences' Property Plant And Equipment Net is projected to increase significantly based on the last few years of reporting. The current year's Accounts Payable is expected to grow to about 11.1 M, whereas Total Assets are forecasted to decline to about 114.4 M. Key indicators impacting Cassava Sciences' financial strength include:
The essential information of the day-to-day investment outlook for Cassava Sciences includes many different criteria found on its balance sheet. An individual investor should monitor Cassava Sciences' cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Cassava Sciences.
Net Income
(92.36 Million)
Cassava
Select Account or Indicator
Market Cap
Enterprise Value
Price To Sales Ratio
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Net Income Per Share
Payables Turnover
Sales General And Administrative To Revenue
Research And Ddevelopement To Revenue
Capex To Revenue
Cash Per Share
Pocfratio
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Operating Cash Flow Sales Ratio
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Price Fair Value
Return On Equity
Cash Conversion Cycle
Change In Cash
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Cashflows From Financing Activities
Depreciation
Other Non Cash Items
Capital Expenditures
Total Cash From Operating Activities
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Stock Based Compensation
Sale Purchase Of Stock
Investments
Total Cashflows From Investing Activities
Cash And Cash Equivalents Changes
Cash Flows Other Operating
Change To Netincome
Change To Liabilities
Other Cashflows From Investing Activities
Change To Operating Activities
Issuance Of Capital Stock
Total Assets
Total Current Liabilities
Total Stockholder Equity
Property Plant And Equipment Net
Net Debt
Retained Earnings
Accounts Payable
Cash
Non Current Assets Total
Cash And Short Term Investments
Net Receivables
Common Stock Total Equity
Common Stock Shares Outstanding
Liabilities And Stockholders Equity
Non Current Liabilities Total
Other Current Assets
Other Stockholder Equity
Total Liab
Property Plant And Equipment Gross
Total Current Assets
Accumulated Other Comprehensive Income
Common Stock
Other Current Liab
Non Currrent Assets Other
Short Term Investments
Current Deferred Revenue
Short Term Debt
Net Tangible Assets
Retained Earnings Total Equity
Capital Surpluse
Property Plant Equipment
Other Assets
Net Invested Capital
Net Working Capital
Capital Stock
Short Long Term Debt Total
Capital Lease Obligations
Non Current Liabilities Other
Depreciation And Amortization
Interest Expense
Total Revenue
Gross Profit
Other Operating Expenses
Operating Income
Ebit
Research Development
Ebitda
Cost Of Revenue
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Income Tax Expense
Selling General Administrative
Net Income From Continuing Ops
Non Operating Income Net Other
Net Income Applicable To Common Shares
Interest Income
Net Interest Income
Reconciled Depreciation
Probability Of Bankruptcy
Understanding current and past Cassava Sciences Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Cassava Sciences' financial statements are interrelated, with each one affecting the others. For example, an increase in Cassava Sciences' assets may result in an increase in income on the income statement.
Please note, the presentation of Cassava Sciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Cassava Sciences' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Cassava Sciences' management manipulating its earnings.
Cassava Sciences Stock Summary
Cassava Sciences competes with Annovis Bio, Axsome Therapeutics, Reviva Pharmaceuticals, Seres Therapeutics, and Anavex Life. Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas. Cassava Sciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 24 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
Comparative valuation techniques use various fundamental indicators to help in determining Cassava Sciences's current stock value. Our valuation model uses many indicators to compare Cassava Sciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cassava Sciences competition to find correlations between indicators driving Cassava Sciences's intrinsic value. More Info.
Cassava Sciences is rated fourth in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Cassava Sciences' Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cassava Sciences' earnings, one of the primary drivers of an investment's value.
Cassava Sciences Systematic Risk
Cassava Sciences' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Cassava Sciences volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Cassava Sciences correlated with the market. If Beta is less than 0 Cassava Sciences generally moves in the opposite direction as compared to the market. If Cassava Sciences Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Cassava Sciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Cassava Sciences is generally in the same direction as the market. If Beta > 1 Cassava Sciences moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Cassava Sciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Cassava Sciences' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Cassava Sciences growth as a starting point in their analysis.
Price Earnings To Growth Ratio
(0.34)
At present, Cassava Sciences' Price Earnings To Growth Ratio is projected to slightly decrease based on the last few years of reporting.
Cassava Sciences November 24, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Cassava Sciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Cassava Sciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Cassava Sciences based on widely used predictive technical indicators. In general, we focus on analyzing Cassava Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Cassava Sciences's daily price indicators and compare them against related drivers.
When running Cassava Sciences' price analysis, check to measure Cassava Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cassava Sciences is operating at the current time. Most of Cassava Sciences' value examination focuses on studying past and present price action to predict the probability of Cassava Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cassava Sciences' price. Additionally, you may evaluate how the addition of Cassava Sciences to your portfolios can decrease your overall portfolio volatility.